320 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AZPN | US$239.10 | 0.8% | 17.9% | US$14.9b | US$239.03 | PS13.4x | E39.8% | n/a | Software | ||
ILMN | US$141.43 | 8.7% | 1.0% | US$21.7b | US$149.23 | PS5.1x | E75.6% | n/a | Pharmaceuticals & Biotech | ||
ORSTED | DKK 418.30 | -7.1% | 25.7% | DKK 175.8b | DKK 465.67 | PS2.4x | E59.1% | 0% | Utilities | ||
FLUT | US$237.53 | -0.3% | 47.5% | US$41.8b | US$261.98 | PS3.3x | E58.6% | 0% | Consumer Services | ||
YPFD | AR$27,350.00 | 2.2% | 174.7% | AR$10.9t | AR$21,810.37 | PB1.1x | E56.0% | 0% | Energy | ||
CLNX | €36.30 | -0.8% | 22.9% | €25.6b | €43.72 | PS6.5x | E84.3% | 0.2% | Telecom | ||
RVTY | US$123.96 | -1.7% | 15.3% | US$15.3b | US$134.48 | PE77.5x | E25.8% | 0.2% | Pharmaceuticals & Biotech | ||
DSFIR | €117.85 | -3.3% | 52.2% | €31.3b | €128.14 | PS2.5x | E44.2% | 0.8% | Materials | ||
STERV | €12.00 | 4.9% | 2.0% | €9.5b | €13.89 | PS1.1x | E42.5% | 0.8% | Materials | ||
ADE | NOK 114.20 | 0.4% | 41.5% | NOK 139.1b | NOK 113.94 | PS6.5x | E83.0% | n/a | Media | ||
A373220 | ₩403,500.00 | -2.7% | -13.0% | ₩94.4t | ₩442,866.67 | PS3.3x | E47.8% | n/a | Capital Goods | ||
GALD | CHF 78.05 | -2.4% | n/a | CHF 19.7b | CHF 82.48 | PS5.3x | E44.2% | n/a | Pharmaceuticals & Biotech | ||
DLTR | US$70.90 | -3.0% | -32.7% | US$14.9b | US$85.73 | PB2.1x | E46.2% | n/a | Consumer Retailing | ||
1COV | €58.36 | 6.3% | 16.5% | €11.0b | €57.79 | PB1.7x | E59.9% | 0% | Materials | ||
PHIA | €29.37 | -0.3% | 75.7% | €27.4b | €27.97 | PS1.5x | E58.8% | n/a | Healthcare | ||
2 | CN¥9.72 | 10.0% | -25.7% | CN¥116.0b | CN¥6.76 | PB0.5x | E78.7% | 0% | Real Estate Management and Development | ||
LYV | US$110.87 | 2.0% | 26.7% | US$25.1b | US$118.86 | PE99.9x | E29.3% | n/a | Media | ||
ZG | US$61.00 | -3.9% | 42.8% | US$14.6b | US$59.49 | PS6.8x | E67.1% | n/a | Real Estate Management and Development | ||
2002 | NT$23.70 | 2.6% | -3.9% | NT$361.4b | NT$24.64 | PE108.7x | E59.8% | 1.5% | Materials | ||
GRAB | US$3.68 | -4.4% | 5.1% | US$14.7b | US$4.65 | PS5.6x | E59.6% | n/a | Transportation | ||
CART | US$40.41 | 1.3% | 58.7% | US$10.2b | US$44.47 | PS3.2x | E64.9% | n/a | Consumer Retailing | ||
1801 | HK$51.15 | 9.8% | 31.2% | HK$83.4b | HK$58.75 | PS10.2x | E59.4% | n/a | Pharmaceuticals & Biotech | ||
500103 | ₹267.45 | -7.0% | 107.4% | ₹931.3b | ₹241.69 | PE338x | E64.4% | 0.09% | Capital Goods | ||
SE | US$95.99 | 1.8% | 126.3% | US$54.6b | US$86.94 | PS3.8x | E49.4% | n/a | Media |